Internal Dosimetry in Patients Undergoing Peptide Receptor Radionuclide Therapy (PRRT) with 177Lu-[DOTA0-Tyr3] Octerotate: A Single-Center Experience

Internal Dosimetry in Patients Undergoing Peptide Receptor Radionuclide Therapy (PRRT) with 177Lu-[DOTA0-Tyr3] Octerotate: A Single-Center Experience

Purpose: Peptide Receptor Radionuclide Therapy (PRRT) with 177Lu-DOTATATE (177 Lu DOTA-TATE therapy is a form of PRRT which targets Somatostatin Receptors (SSR). It is a form of targeted drug delivery, which is applicable to treat neuroendocrine tumors. PRRT applications are continuously expanding...

Full description

Saved in:
Bibliographic Details
Main Authors: Elahe Mahmoudi, Mahasti Amoui, Mohammad Reza Deevband, Elahe Pirayesh, Mohammad Reza Asgari, Mehdi Ghorbani
Format: Article
Language:English
Published: Tehran University of Medical Sciences 2025-01-01
Series:Frontiers in Biomedical Technologies
Subjects:
Individualized Dosimetry
177Lu-DOTA0
Tyr3-Octreotate
Neuroendocrine Tumors
Organ at Risk
Online Access:https://fbt.tums.ac.ir/index.php/fbt/article/view/655
Tags: Add Tag
No Tags, Be the first to tag this record!
Be the first to leave a comment!
You must be logged in first

Similar Items